by Alpha | Nov 1, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
2. CVX:$CVX upgraded to Overweight at Morgan Stanley – PT raise $130 from $113
DOWNGRADES
1. BHI:$BHI downgraded to Outperform at Raymond James
EARNINGS
Trending Social Alerts
1. PFE:$PFE discontinues development of its PCSK9 inhibitor.
4. BHI:$BHI downgraded to Outperform at Raymond James
5. BABA:surprised Ackman isn’t long $BABA, has accounting irregularities, whistle-blowers and SEC investigations
6. COH:Coach Q1 EPS $0.45 vs $0.45 Est, Revenue $1.04B vs $1.07B Est. $COH
8. SHPG:$SHPG terminates SHP610 after Ph2b study did not meet primary endpoint of slowing cognitive decline in pts with early stage #Sanfilippo A.
Trending News Headlines
1. ‘High-up’ Alibaba staffer helping SEC probe into tech giant
A federal probe of Alibaba’s books is far from dead — and it’s getting help from at least one insider. The Securities and Exchange Commission is working with one or more whistleblowers as it invest…
2. Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor | Pfizer: One of the world’s premier biopharmaceutical companies
Pfizer Inc. announced today the discontinuation of the global clinical development program for bococizumab, its investigational Proprotein Convertase Subtilisin Kexin type 9 inhibitor (PCSK9i). The totality of clinical information now available for bococizumab, taken together with the evolving treatment and market landscape for lipid-lowering agents, indicates that bococizumab is not likely to provide value to patients, physicians, or shareholders. As a result, Pfizer has decided to discontinue the development program, including the two ongoing cardiovascular outcome studies.
3. Pfizer Cuts Outlook, Ends Development of Cholesterol Drug
Pfizer Inc. on Tuesday lowered its earnings outlook for the year and said it was ending the development of a drug in the massive cholesterol-treatment sector.
4. Pfizer profit just misses; company scraps cholesterol drug
Pfizer Inc (PFE.N), the largest U.S. drugmaker, reported a quarterly adjusted profit that just missed analysts’ estimates, and the company shaved 4 cents off its 2016 earnings forecast after scrapping development of a cholesterol-lowering treatment.
5. Gannett ends talks to buy Tronc
This story is developing. Please check back for further updates.
6. Gannett Abandons Its Attempt to Buy Tronc
Newspaper company Gannett has dropped its bid to buy Chicago Tribune publisher Tronc, ending a monthslong pursuit of its rival.
7. Tronc is crashing after Gannett terminates buyout talks
The owner of the USA Today is not buying the owner of the Chicago Tribune and the stocks are crashing.
8. Gannett Abandons Effort to Buy Newspaper Publisher Tronc
Investor expectations will now present tough questions for the former Tribune Publishing, owner of The Los Angeles Times and Chicago Tribune.
9. SAP Ariba Celebrates Two Decades of Procurement Innovation
Twenty years ago, procurement was a manual function driven largely by phone calls, faxes and handshakes. Then along came the Internet. And a company n
10. Drugmaker Sanofi hungry for deals after earnings beat
French drugmaker Sanofi stepped up its overhaul on Friday, putting its European generic drugs business up for sale and saying that a planned 3.5 billion euro ($3.8 billion) share buyback would not suppress its appetite for deals.
11. Press Release | Investor Relations | Ionis Pharmaceuticals
CARLSBAD, Calif. , Nov. 1, 2016 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced positive data from a Phase 2 placebo-controlled study evaluating IONIS-FXI Rx in patients with end-stage renal disease (ESRD) on hemodialysis. In this Phase 2 study patients treated with IONIS-FXI Rx achieved statistically significant, dose-dependent reductions in Factor XI activity. There were no clinically meaningful reductions in platelet levels and no treatment-related major or clinically relevant non-major bleeding events.
Technology News
by Alpha | Oct 31, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
3. AGN, HZNP, TEVA:Mizuho cut $hznp PT ahead of earnings. CS upgrades $teva to outperform. Barclays reiterates = weight for $agn.
8. CVX:$CVX upgraded to Buy at Goldman Sachs
9. DE:$DE upgraded to Outperform at Baird
13. INVA:$inva upgraded to outperform by Cowen.
20. QCOM:$QCOM upgraded to Buy at Nomura
23. TEVA:$TEVA upgraded to Outperform at Credit Suisse – PT cut $52 from $59
DOWNGRADES
3. BIDU:$BIDU downgraded to Neutral at Macquarie
7. HD:$HD downgraded to neutral at PiperJaffray
13. NKE:$NKE downgraded to Underperform at Bank of America
16. XOM:$XOM downgraded to Neutral at GoldmanSachs
EARNINGS
Trending Social Alerts
1. ARIA:$ARIA – brigatinib PDUFA April 29, 2017.
4. CAH:$CAH Cardinal Health Q1 17 Earnings Results: -Adj EPS: $1.24 -Revenue: $32B
Trending News Headlines
1. GE to Combine Oil and Gas Business With Baker Hughes
General Electric reached a deal to combine its oil-and-gas business with Baker Hughes, creating a publicly traded energy powerhouse that would give GE a cost-effective way to play any recovery in the industry.
2. Bauer ice hockey gear maker files bankruptcy in U.S. and Canada
Performance Sports Group Ltd (PSG.TO) (PSG.N), the maker of Bauer ice hockey gear, said on Monday it has filed for bankruptcy protection in the United States and Canada to facilitate a restructuring and sale of almost all of its assets.
3. TeamHealth to be Acquired by Blackstone
KNOXVILLE, Tenn., Oct. 31, 2016 /PRNewswire/ — TeamHealth Holdings, Inc. (“TeamHealth” or the “Company”) (NYSE:…
4. Ophthotech Announces the Publication of Fovista® in Combination with Lucentis® Phase 2b Study Results in Ophthalmology®, the Journal of the American Academy of Ophthalmology
Ophthotech Corporation today announced that the Phase 2b study results of Fovista® , the Company’s anti-PDGF agent administered in combination with Lucentis® anti-VEGF therapy for the treatment of wet age-related macular degeneration , have been published online in Ophthalmology®, the journal of
5. ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system disorders, today announced the initiation of SERENE, a Phase II study with pimavanserin for the treatment of agitation in patients with Alzheimer’s disease
6. Why After A Massive Run, CoLucid Shares Still Look Attractive
Mirgraine, CoLucid, NASDAQ:CLCD, BioNap, JNapodano, lasmiditan
7. MGM Resorts ready to bet up to $10 billion on Japan casino, possibly via REIT
Las Vegas-based MGM Resorts International (MGM.N) could plow almost $10 billion into a Japanese casino via a publicly traded real estate investment trust, its chief executive said on Monday, as Tokyo inches closer to legalizing the industry.
8. CenturyLink to Buy Level 3 Communications for $25 Billion
CenturyLink Inc. said Monday that it reached a cash-and-stock deal to buy Level 3 Communications Inc. for roughly $25 billion, a marriage that would give the communications companies more heft to weather a competitive landscape.
9. GE Nears Deal to Combine Oil-and-Gas Business With Baker Hughes
General Electric Co. is nearing a roughly $30 billion deal to combine its oil-and-gas business with Baker Hughes Inc., creating an energy powerhouse that would give GE a cost-effective way to play any recovery in the industry.
Technology News
by Alpha | Oct 28, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
2. ALXN:$ALXN upgraded from Underperform to Mkt Perform at FBR. PT $130
3. COP:$COP upgraded to Overweight at PiperJaffray
8. TWTR:$TWTR maintains Buy rating at Goldman Sachs – PT cut $22 from $23, upgraded to Perform at Oppenheimer
DOWNGRADES
2. BIDU:$BIDU downgrades to Neutral at Credit Suisse – PT cut $173 from $184
5. EA:$EA downgraded to Market Perform at Cowen & Co
EARNINGS
Trending Social Alerts
1. XOM:$XOM Exxon Mobil Q3 16 Earnings Results: -Adj EPS: $0.63 -Revenue: $58.68B
6. MA:Mastercard Reports Q3 EPS $1.08 vs $0.98 Est., Sales $2.9B vs $2.75B Est. $MA
7. OPXA:$OPXA halted news pending
Trending News Headlines
1. General Electric Pursues Deal With Baker Hughes
GGeneral Electric is in talks to merge its oil-and-gas business with Baker Hughes, according to people familiar with the matter, a transaction that would dramatically reshape the industrial giant.
2. Apple Has Raised Computer Prices by 20% Because of Brexit
Apple Inc. quietly raised the cost of some of its products in Britain by 20 percent, the latest blow to U.K. consumers after the decision to leave the European Union sent the pound sliding.
3. j l on Twitter
“$CEMP manufacturing woes as detailed in the 10Q”
Technology News
by Alpha | Oct 26, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
3. PRTO:$PRTO upgraded to Strong Buy from Outperform at Raymond James. PT $19
4. TWX:$TWX upgraded to Overweight at Barclays – PT raise $95 from $74
DOWNGRADES
1. CMG:$CMG downgraded to Neutral at Credit Suisse – PT cut $375 from $500
3. GM:$GM downgraded to Neutral at Bank of America
5. P:$P downgraded to Underweight at Albert Fried – PT cut $8 from $16
6. RIG:$RIG downgraded to Underweight at Morgan Stanley
7. T:$T downgraded to Equal-Weight at Barclay
EARNINGS
Trending Social Alerts
1. BIIB:$BIIB Q3 Tecfidera sales $1.03B, slight beat but helped by $40-50M inventory build.
2. LUV:Southwest Airlines Q3 EPS $0.93 vs $0.88 est, Revenue $5.14B vs $5.17B est. $LUV
3. CMCSA:EARNINGS ALERT: Comcast EPS beats $0.92 vs. $0.91 • revs. beat $21.319B vs. $21.165B $CMCSA
4. BA:Boeing Q3 EPS $3.51 vs $2.62 est, Revenue $23.9B vs $23.6B est. $BA
5. KO:Coca Cola Q3 EPS $0.49 vs $0.48 est, Revenue $10.63B vs $10.51B est. $KO
6. SIX:$SIX results look pretty dismal after 7,000 Nov. $50 puts bought yesterday into the report
8. NERV:$NERV Announces Positive Data From Six-Month Extension of Phase IIb Trial of MIN-101 Monotherapy in Schizophrenia
10. VRTX:Why is $VRTX incapable of providing investors with unambiguously good news? There’s always drama, something to worry about.
12. PNRA:$PNRA :”Trade Idea 1: Buy the November 195/190-185 1×2 Put Spread for a $1 credit.” keep the credit, can BTC 185 to release margin
Trending News Headlines
1. Here’s How Goldman Sachs Fires People
The first “plant layoff” notice came in February: 43 people would lose their jobs.
2. Biogen profit beats estimates on sales of MS drug
By
3. U.S. warned Berlin on China-Aixtron deal: Handelsblatt
U.S. intelligence services warned Berlin that a now on-hold Chinese takeover of German semiconductor equipment maker Aixtron (AIXGn.DE) could give Beijing access to technology that could be used for military purposes, business daily Handelsblatt said.
4. Comcast Reports Strong Earnings, Powered by Rio Olympics
Comcast Corp. reported better-than-expected financial results and added video customers in the third quarter, as its NBCUniversal business saw strong growth powered by the Rio Olympics.
Technology News
If you enjoy the content from SeekingOptions, please like our Facebook page and subscribe to our Youtube Channel
by Alpha | Oct 25, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
3. CHK:$CHK upgraded to Sector Perform at RBC Capital
DOWNGRADES
1. ARIA:$ARIA downgraded to Market Perform at JMP Securities.
8. V:$V downgraded to Neutral at Guggenheim, maintains Buy rating at UBS – PT raise $97 from $90
9. VFC:$VFC downgraded to Hold at Deutsche Bank – PT raise $97 from $90, maintains Buy rating at UBS – PT cut $59 from $65
EARNINGS
Trending Social Alerts
1. MRK:$MRK Merck & Co Q3 16 Earnings Results: -Adj EPS: $1.07 -Revenue: $10.5B
2. UA:Under Armour Reports Q3 EPS $0.29 vs $0.25 Est., Sales $1.472B vs $1.45B Est. $UA
6. UTX:$UTX United Technologies Q3 16 Earnings Results: -Adj EPS: $1.76 -Revenue: $14.4B
9. NVS:Strong indication from Jimenez on conf call that $NVS would love to sell Roche stake to buy bolt-on instead – actively looking
11. DD:#jimcramer $DD raises 2016 operating profit guidance – my RealMoneyPro long standing favorite large cap for 2016
13. DPRX:$DPRX halt
14. PG:P&G Reports Q1 Adj. EPS $1.03 vs $0.98 Est., Sales $16.52B vs $16.5B Est. $PG
15. MMM:$GM crushes numbers, “Automotive Strength” a theme across multiple industry reports including $MMM and $DD today
Trending News Headlines
1. Bear thesis on Corbus Pharma could cause a crash landing for high-flying biotech stock
The market is acting like resunab is a real drug, which is why my investor source is short Corbus.
2. Twitter Planning Hundreds More Job Cuts as Soon as This Week
Twitter Inc. is planning widespread job cuts, to be announced as soon as this week, according to people familiar with the matter.
3. Caterpillar Lowers Sales Forecast as Rebound Proves Elusive
Caterpillar Inc., the biggest maker of construction and mining equipment, cut its 2016 revenue forecast and said next year won’t be much different as companies defer purchases amid sluggish growth and low commodity price expectations. Shares fell.
4. Merck Announces Third-Quarter 2016 Financial Results | Merck Newsroom Home
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2016.
5. Under Armour Tumbles After Forecast Renews Fears of Slowdown
Under Armour Inc. shares fell as much as 18 percent in early trading after its long-term forecast renewed fears that the athletic brand’s growth streak is finally sputtering.
6. New Results Presented for Opdivo (nivolumab) Demonstrate Encouraging Response Rate in an Expanded Population of Heavily Pre-Treated Classical Hodgkin Lymphoma Patients | Business Wire
New Results Presented for Opdivo (nivolumab) Demonstrate Encouraging Response Rate in an Expanded Population of Heavily Pre-Treated Classical Hodgkin
7. Pfizer cuts price of Enbrel to match rival ‘biosimilar’ drug
Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association
8. Syngenta-ChemChina Deal Closing Likely to Be Delayed
Swiss seed and pesticide maker Syngenta said regulatory approval of its proposed acquisition by ChemChina is likely to be delayed into early 2017 as regulators seek more information amid a consolidation wave in the sector.
9. Baker Hughes posts smaller-than-expected loss as cost cuts pay off
Oilfield services provider Baker Hughes Inc (BHI.N) reported a much smaller-than-expected quarterly loss as the company’s aggressive cost-cutting measures paid off.
10. Sheff on Twitter
“$TGTX..$6.23..Key Milestones & $15 PT valuation (Sun)”
11. UPDATE: Chardan Capital Markets Starts Clovis Oncology (CLVS) at ‘Sell’ With Price Target of $15
(Updated – October 25, 2016 8:28 AM EDT) Chardan Capital Markets initiated coverage on Clovis Oncology (NASDAQ: CLVS) with a Sell rating and a price target of $15. Analyst Madhu Kumar doesn’t…
12. Uber’s Otto hauls Budweiser across Colorado in self-driving truck
In the first real-world commercial use of autonomous trucking, some 45,000 cans of Budweiser beer arrived late last week to a warehouse after traveling over 120 highway miles in a self-driving truck with no driver at the wheel, executives from Uber [UBER.UL] and Anheuser-Busch (ABI.BR) said.
13. Goldman, closer to Murdoch than Bugs Bunny, misses year’s biggest deal
It has been six years since Goldman Sachs Group Inc, a perennial No. 1 in the M&A league tables, did not feature as an adviser on the year’s biggest deal. But sticking with Rupert Murdoch over Bugs Bunny just cost it this year’s biggest deal.
Technology News
Meanwhile in Europ
The European banks are in much worse shape than their US competition. The reason being argued in Europe is that the US government imposed a ban on speculation
Today’s Economic Calendar
8:55 Redbook Chain Store Sales
9:00 FHFA House Price Index
9:00 S&P Case-Shiller Home Price Index
10:00 Consumer Confidence
10:00 Richmond Fed Mfg.
10:00 State Street Investor Confidence Index
1:00 PM Results of $26B, 2-Year Note Auction
1:20 PM Fed’s Lockhart speech
If you enjoy the content from SeekingOptions, please like our Facebook page and subscribe to our Youtube Channel
by Alpha | Oct 24, 2016 | Pre-Market
PRE-MARKET MOVERS
UPGRADES
3. CHK:WOW another $CHK UPGRADE!!! DJ Chesapeake Energy Raised to Equal-Weight From Underweight by Stephens & Co. Mon Oct 24 08:36:10 2016
4. DKS:$DKS upgraded to Outperform at Cowen & Co
9. KMI:$KMI upgraded to Outperform at BMO Capital
12. WYNN:$WYNN upgraded to Overweight by Morgan Stanley
DOWNGRADES
1. ADAP:$ADAP downgraded to Underperform from Neutral at BofA.
4. EA:$EA downgraded to Neutral at Bank of America
7. T:$T downagraded to Market Perform at Cowen & Co, downgraded to Hold at Drexel Hamilton
8. TEVA:$TEVA downgraded to Neutral at Mizuho
EARNINGS
Trending Social Alerts
1. INO:$INO halted
2. T:I can’t wait for “vertical integration” to start trending on Twitter, said no one to nobody. $T $TWX
3. ADRO:$ADRO halted
5. BIDU:Hearing Baidu $BIDU is gapping up on a early AM upgrade at OTR
7. AMTD:It’s like the AT&T-Time Warner deal for online brokers! Okay. Not exactly. But TD Ameritrade scooping up Scottrade for $4B. $AMTD
8. HLT:HNA buying 25% stake in Hilton $HLT for $26.25/share cash, $6.5B. Reduces Blackstone investment in HLT to 21%
9. KMB:$KMB Kimberly-Clark Q3 16 Earnings Results: -Adj EPS: $1.52 -Revenue: $4.59B
Trending News Headlines
1. Apple is sitting on ‘a powder keg of dramatically aging’ iPhones
Apple reports its September quarter earnings…
2. TD Ameritrade is buying Scottrade for $4 billion
The retail broker TD Ameritrade is buying the discount brokerage Scottrade for about $4 billion.
Technology News
Today’s Economic Calendar
8:30 Chicago Fed National Activity Index
9:00 Fed’s Dudley: “Evolving Structure of the U.S. Treasury Market”
9:05 Fed’s Bullard speech
9:45 PMI Manufacturing Index Flash
1:45 PM Fed’s Powell: “Future of the settlement process for Treasury market”